Cited by 53Metabolism, Diabetes, and CancerGenetics, Aging, and Longevity in Model OrganismsTelomeres, Telomerase, and Senescence

Genome protective effect of metformin as revealed by reduced level of constitutive DNA damage signaling

Open access
Halicka, H. Dorota, Zhao, Hong, Li, Jiangwei, Traganos, Frank, Zhang, Sufang, Lee, Marietta, Darzynkiewicz, Zbigniew·2011·Aging

Abstract

We have shown before that constitutive DNA damage signaling represented by H2AX-Ser139 phosphorylation and ATM activation in untreated normal and tumor cells is a reporter of the persistent DNA replication stress induced by endogenous oxidants, the by-products of aerobic respiration. In the present study we observed that exposure of normal mitogenically stimulated lymphocytes or tumor cell lines A549, TK6 and A431 to metformin, the specific activator of 5'AMP-activated protein kinase (AMPK) and an inhibitor of mTOR signaling, resulted in attenuation of constitutive H2AX phosphorylation and ATM activation. The effects were metformin-concentration dependent and seen even at the pharmacologically pertinent 0.1 mM drug concentration. The data also show that intracellular levels of endogenous reactive oxidants able to oxidize 2',7'-dihydro-dichlorofluorescein diacetate was reduced in metformin-treated cells. Since persistent constitutive DNA replication stress, particularly when paralleled by mTOR signaling, is considered to be the major cause of aging, the present findings are consistent with the notion that metformin, by reducing both DNA replication stress and mTOR-signaling, slows down aging and/or cell senescence processes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/aging.100397

Cites

80 of 80 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In a dose-dependent manner, metformin prevents activation of ATM protein kinase, lowering ROS and gammaH2AX.

    “in a dose-dependent manner, metformin prevents activation of ATM-protein kinase, thereby lowering ROS and γH2AX-a sensitive marker of DNA-double stranded breaks and genomic instability”

    From Benefits of Metformin in Attenuating the Hallmarks of Aging (2020) · cites this paper as Halicka et al. 2011

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Halicka, H. D., Zhao, H., Li, J., Traganos, F., Zhang, S., Lee, M., & Darzynkiewicz, Z.
Affiliations
  • New York Medical College (US)
  • Brander Cancer Research Institute and Department of Pathology, New York Medical College, Valhalla, NY 10595, USA
Venue
Aging
Published
2011-10-28
Volume
3
Issue
10
Pages
1028-1038
ISSN
1945-4589 (ISSN-L)
OpenAlex
W2120518749
Cited by
53
References
80
Citations by year
2025: 1 · 2024: 3 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 2 · 2019: 6 · 2018: 3 · 2017: 2 · 2016: 4 · 2015: 5 · 2014: 4 · 2013: 5 · 2012: 14
FWCI
3.12
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Aging (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Cancer Institute (R01CA028704)
  • National Institute of General Medical Sciences (R01GM031973)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
Keywords
metformin, DNA damage signaling, H2AX phosphorylation, ATM activation, replication stress, reactive oxygen species, AMPK, mTOR signaling, cellular senescence, lymphocytes, lung cancer cells
MeSH terms
Animals, Cell Line, DNA, DNA Damage, DNA Replication, DNA-Binding Proteins, Histones, Humans, Hypoglycemic Agents, Metformin, Signal Transduction, Genome, Protein Serine-Threonine Kinases, Reactive Oxygen Species, Cell Cycle Proteins, Tumor Suppressor Proteins, TOR Serine-Threonine Kinases, Ataxia Telangiectasia Mutated Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review